| HOME >> MEDICINE >> TECHNOLOGY |
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack
Trial, Hypertension 2007; 50; 854-861
(3) Sharma, Arya, et al. Antihypertensive Effect of Irbesartan and
Predictors of Response in Obesity-Associated Hypertension. Clin Drug
Invest. 2005; 25(12): 765-776
(4) Chobanian, A.V., et al. Seventh report of the Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of High
Blood Pressure. Hyperten. 2003; 42(6): 1206-52
(5) http://www.cdc.gov/nchs/nhanes.htm Site accessed 5/14/2008
(6) Chobanian, A.V., et al. Seventh report of the Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of High
Blood Pressure. Hyperten. 2003; 42(6): 1206-52
(7) http://www.americanheart.org/presenter.jhtml?identifier=2114 Site
accessed 5/17/2007
(8) http://www.americanheart.org/presenter.jhtml?identifier=4621 Site
accessed 5/11/2007
(9) Ong KL, et al. Prevalence, awareness, treatment and control of
hypertension among United States Adults 1999-2004. Hypertens 2007;
49: 69-75
(10) Margolis et al. Blood Pressure Control in Hispanics in the
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack
Trial, Hypertension 2007; 50; 854-861
(11) Chobanian AV, et al. The Seventh Report of the Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of High
Blood Pressure: the JNC Report. JAMA 2003; 289: 2560-2572
(12) Douglas JG, et al. Management of high blood pressure in African
Americans. Consensus Sta
'/>"/>
| SOURCE Daiichi Sankyo, Inc. Copyright©2008 PR Newswire. All rights reserved |